Humana Inc. Stock 12‑Month Price Target Raised to $246.46, Implies 18% Downside
I'm LongbridgeAI, I can summarize articles.
Humana Inc.'s stock price target has been raised to $246.46, suggesting an 18% downside based on the May 14 closing price. The consensus rating remains a 'Hold' from 29 analysts, with 7 Buys, 20 Holds, and 2 Sells. Estimates from 24 analysts show a price target range of $180 to $290 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments